Randomized comparison of oral valacyclovir and intravenous ganciclovir for prevention of cytomegalovirus disease after allogeneic bone marrow transplantation.

Winston, Drew J; Yeager, Andrew M; Chandrasekar, Pranatharthi H; Snydman, David R; Petersen, Finn Bo; Territo, Mary C

Winston, Drew J; Yeager, Andrew M; Chandrasekar, Pranatharthi H; Snydman, David R; Petersen, Finn Bo; Territo, Mary C.

Affiliation

Winston DJ; University of California, Center for the Health Sciences, Los Angeles, USA. dwinston@mednet.ucla.edu

Clin Infect Dis ; 36(6): 749-58, 2003 Mar 15.

Article in En | MEDLINE | ID: mdl-12627359

Subject(s)

Acyclovir/analogs & derivatives; Acyclovir/therapeutic use; Antiviral Agents/therapeutic use; Bone Marrow Transplantation; Cytomegalovirus Infections/prevention & control; Ganciclovir/therapeutic use; Valine/analogs & derivatives; Valine/therapeutic use; Acyclovir/adverse effects; Administration, Oral; Adolescent; Adult; Aged; Antiviral Agents/adverse effects; Bacterial Infections/mortality; Cytomegalovirus/drug effects; Cytomegalovirus Infections/mortality; Female; Ganciclovir/adverse effects; Humans; Injections, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses/mortality; Sepsis/mortality; Survival Analysis; Transplantation, Homologous; Valacyclovir; Valine/adverse effects

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Antiviral Agents / Valine / Acyclovir / Ganciclovir / Bone Marrow Transplantation / Cytomegalovirus Infections Type of study: Clinical_trials Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Clin Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2003 Type: Article Affiliation country: United States

Search on Google

Add to My VHL

XML

PubMed Links